カテゴリー： QYResearch, 世界

世界の併用療法薬市場

◆英語タイトル：Global Combination Therapy Drug Market Professional Survey Report 2019
◆商品コード：DATA909X05664
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、併用療法薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他に、用途別には、がん、心血管疾患、免疫疾患にセグメント区分し、併用療法薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・併用療法薬の世界市場概要
・併用療法薬の製造コスト構成分析
・併用療法薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・併用療法薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・併用療法薬のセグメント分析（種類別）
（グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他）
・併用療法薬のセグメント分析（用途別）
（がん、心血管疾患、免疫疾患）
・併用療法薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（CSL Ltd、Grifols S.A、Baxalta Incorporated、Octapharma AG、Kedrion S.p.A、Biotest AG、China Biologic Products、）
・併用療法薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Combination Therapy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Combination Therapy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combination Therapy Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Combination Therapy Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Combination Therapy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
CSL Ltd
Grifols S.A
Baxalta Incorporated
Octapharma AG
Kedrion S.p.A
Biotest AG
China Biologic Products
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Diammonium Glycyrrhizinate
Interferon and Nucleoside Drugs
Targeted Therapies Drugs
Others

Segment by Application
Cancer
Cardiovascular Disease
Immune Disease

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Combination Therapy Drug
1.1 Definition of Combination Therapy Drug
1.2 Combination Therapy Drug Segment by Type
1.2.1 Global Combination Therapy Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diammonium Glycyrrhizinate
1.2.3 Interferon and Nucleoside Drugs
1.2.4 Targeted Therapies Drugs
1.2.5 Others
1.3 Combination Therapy Drug Segment by Applications
1.3.1 Global Combination Therapy Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Cancer
1.3.3 Cardiovascular Disease
1.3.4 Immune Disease
1.4 Global Combination Therapy Drug Overall Market
1.4.1 Global Combination Therapy Drug Revenue (2014-2025)
1.4.2 Global Combination Therapy Drug Production (2014-2025)
1.4.3 North America Combination Therapy Drug Status and Prospect (2014-2025)
1.4.4 Europe Combination Therapy Drug Status and Prospect (2014-2025)
1.4.5 China Combination Therapy Drug Status and Prospect (2014-2025)
1.4.6 Japan Combination Therapy Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Combination Therapy Drug Status and Prospect (2014-2025)
1.4.8 India Combination Therapy Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Combination Therapy Drug
2.3 Manufacturing Process Analysis of Combination Therapy Drug
2.4 Industry Chain Structure of Combination Therapy Drug

3 Development and Manufacturing Plants Analysis of Combination Therapy Drug
3.1 Capacity and Commercial Production Date
3.2 Global Combination Therapy Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Combination Therapy Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Combination Therapy Drug Production and Capacity Analysis
4.2 Combination Therapy Drug Revenue Analysis
4.3 Combination Therapy Drug Price Analysis
4.4 Market Concentration Degree

5 Combination Therapy Drug Regional Market Analysis
5.1 Combination Therapy Drug Production by Regions
5.1.1 Global Combination Therapy Drug Production by Regions
5.1.2 Global Combination Therapy Drug Revenue by Regions
5.2 Combination Therapy Drug Consumption by Regions
5.3 North America Combination Therapy Drug Market Analysis
5.3.1 North America Combination Therapy Drug Production
5.3.2 North America Combination Therapy Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Combination Therapy Drug Import and Export
5.4 Europe Combination Therapy Drug Market Analysis
5.4.1 Europe Combination Therapy Drug Production
5.4.2 Europe Combination Therapy Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Combination Therapy Drug Import and Export
5.5 China Combination Therapy Drug Market Analysis
5.5.1 China Combination Therapy Drug Production
5.5.2 China Combination Therapy Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Combination Therapy Drug Import and Export
5.6 Japan Combination Therapy Drug Market Analysis
5.6.1 Japan Combination Therapy Drug Production
5.6.2 Japan Combination Therapy Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Combination Therapy Drug Import and Export
5.7 Southeast Asia Combination Therapy Drug Market Analysis
5.7.1 Southeast Asia Combination Therapy Drug Production
5.7.2 Southeast Asia Combination Therapy Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Combination Therapy Drug Import and Export
5.8 India Combination Therapy Drug Market Analysis
5.8.1 India Combination Therapy Drug Production
5.8.2 India Combination Therapy Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Combination Therapy Drug Import and Export

6 Combination Therapy Drug Segment Market Analysis (by Type)
6.1 Global Combination Therapy Drug Production by Type
6.2 Global Combination Therapy Drug Revenue by Type
6.3 Combination Therapy Drug Price by Type

7 Combination Therapy Drug Segment Market Analysis (by Application)
7.1 Global Combination Therapy Drug Consumption by Application
7.2 Global Combination Therapy Drug Consumption Market Share by Application (2014-2019)

8 Combination Therapy Drug Major Manufacturers Analysis
8.1 CSL Ltd
8.1.1 CSL Ltd Combination Therapy Drug Production Sites and Area Served
8.1.2 CSL Ltd Product Introduction, Application and Specification
8.1.3 CSL Ltd Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Grifols S.A
8.2.1 Grifols S.A Combination Therapy Drug Production Sites and Area Served
8.2.2 Grifols S.A Product Introduction, Application and Specification
8.2.3 Grifols S.A Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Baxalta Incorporated
8.3.1 Baxalta Incorporated Combination Therapy Drug Production Sites and Area Served
8.3.2 Baxalta Incorporated Product Introduction, Application and Specification
8.3.3 Baxalta Incorporated Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Octapharma AG
8.4.1 Octapharma AG Combination Therapy Drug Production Sites and Area Served
8.4.2 Octapharma AG Product Introduction, Application and Specification
8.4.3 Octapharma AG Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Kedrion S.p.A
8.5.1 Kedrion S.p.A Combination Therapy Drug Production Sites and Area Served
8.5.2 Kedrion S.p.A Product Introduction, Application and Specification
8.5.3 Kedrion S.p.A Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Biotest AG
8.6.1 Biotest AG Combination Therapy Drug Production Sites and Area Served
8.6.2 Biotest AG Product Introduction, Application and Specification
8.6.3 Biotest AG Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 China Biologic Products
8.7.1 China Biologic Products Combination Therapy Drug Production Sites and Area Served
8.7.2 China Biologic Products Product Introduction, Application and Specification
8.7.3 China Biologic Products Combination Therapy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Combination Therapy Drug Market
9.1 Global Combination Therapy Drug Market Trend Analysis
9.1.1 Global Combination Therapy Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Combination Therapy Drug Regional Market Trend
9.2.1 North America Combination Therapy Drug Forecast 2019-2025
9.2.2 Europe Combination Therapy Drug Forecast 2019-2025
9.2.3 China Combination Therapy Drug Forecast 2019-2025
9.2.4 Japan Combination Therapy Drug Forecast 2019-2025
9.2.5 Southeast Asia Combination Therapy Drug Forecast 2019-2025
9.2.6 India Combination Therapy Drug Forecast 2019-2025
9.3 Combination Therapy Drug Market Trend (Product Type)
9.4 Combination Therapy Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Combination Therapy Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Combination Therapy Drug
Table Global Combination Therapy Drug Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Combination Therapy Drug Production Market Share by Types in 2018
Figure Diammonium Glycyrrhizinate Product Picture
Figure Interferon and Nucleoside Drugs Product Picture
Figure Targeted Therapies Drugs Product Picture
Figure Others Product Picture
Table Global Combination Therapy Drug Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Combination Therapy Drug Consumption Market Share by Applications in 2018
Figure Cancer
Figure Cardiovascular Disease
Figure Immune Disease
Figure Global Combination Therapy Drug Revenue (Million USD) (2014-2025)
Figure Global Combination Therapy Drug Production (K MT) (2014-2025)
Figure North America Combination Therapy Drug Market Size (Million USD) (2014-2025)
Figure Europe Combination Therapy Drug Market Size (Million USD) (2014-2025)
Figure China Combination Therapy Drug Market Size (Million USD) (2014-2025)
Figure Japan Combination Therapy Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Combination Therapy Drug Market Size (Million USD) (2014-2025)
Figure India Combination Therapy Drug Market Size (Million USD) (2014-2025)
Table Combination Therapy Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Combination Therapy Drug in 2018
Figure Manufacturing Process Analysis of Combination Therapy Drug
Figure Industry Chain Structure of Combination Therapy Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Combination Therapy Drug Manufacturing Plants Distribution
Table Combination Therapy Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Combination Therapy Drug Capacity (K MT) of Major Manufacturers (2014-2019)
Table Combination Therapy Drug Production (K MT) of Major Manufacturers (2014-2019)
Table Combination Therapy Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Combination Therapy Drug Production Share by Manufacturers in 2018
Table Combination Therapy Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Combination Therapy Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Combination Therapy Drug Revenue Share by Manufacturers in 2018
Table Combination Therapy Drug Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Combination Therapy Drug Production by Regions 2014-2019 (K MT)
Table Global Combination Therapy Drug Production Market Share by Regions 2014-2019
Figure Global Combination Therapy Drug Production Market Share by Regions in 2018
Table Global Combination Therapy Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Combination Therapy Drug Revenue Market Share by Regions 2014-2019
Figure Global Combination Therapy Drug Revenue Market Share by Regions in 2018
Table Global Combination Therapy Drug Consumption by Regions 2014-2019 (K MT)
Table Global Combination Therapy Drug Consumption Market Share by Regions 2014-2019
Figure North America Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure North America Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure Europe Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure Europe Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure China Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure China Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure Japan Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure Japan Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure Southeast Asia Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure India Combination Therapy Drug Production Growth Rate 2014-2019 (K MT)
Figure India Combination Therapy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Combination Therapy Drug Production, Consumption Import and Export (K MT)
Figure Global Consumption Combination Therapy Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Combination Therapy Drug Market Share by Application (2014-2019)
Table CSL Ltd Combination Therapy Drug Production Sites and Area Served
Table CSL Ltd Combination Therapy Drug Product Introduction, Application and Specification
Table CSL Ltd Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table CSL Ltd Combination Therapy Drug Production Growth Rate (2014-2019)
Table CSL Ltd Combination Therapy Drug Production Market Share (2014-2019)
Figure CSL Ltd Combination Therapy Drug Revenue Market Share (2014-2019)
Table CSL Ltd Combination Therapy Drug Main Business and Markets Served
Table Grifols S.A Combination Therapy Drug Production Sites and Area Served
Table Grifols S.A Combination Therapy Drug Product Introduction, Application and Specification
Table Grifols S.A Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Grifols S.A Combination Therapy Drug Production Growth Rate (2014-2019)
Table Grifols S.A Combination Therapy Drug Production Market Share (2014-2019)
Figure Grifols S.A Combination Therapy Drug Revenue Market Share (2014-2019)
Table Grifols S.A Combination Therapy Drug Main Business and Markets Served
Table Baxalta Incorporated Combination Therapy Drug Production Sites and Area Served
Table Baxalta Incorporated Combination Therapy Drug Product Introduction, Application and Specification
Table Baxalta Incorporated Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Baxalta Incorporated Combination Therapy Drug Production Growth Rate (2014-2019)
Table Baxalta Incorporated Combination Therapy Drug Production Market Share (2014-2019)
Figure Baxalta Incorporated Combination Therapy Drug Revenue Market Share (2014-2019)
Table Baxalta Incorporated Combination Therapy Drug Main Business and Markets Served
Table Octapharma AG Combination Therapy Drug Production Sites and Area Served
Table Octapharma AG Combination Therapy Drug Product Introduction, Application and Specification
Table Octapharma AG Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Octapharma AG Combination Therapy Drug Production Growth Rate (2014-2019)
Table Octapharma AG Combination Therapy Drug Production Market Share (2014-2019)
Figure Octapharma AG Combination Therapy Drug Revenue Market Share (2014-2019)
Table Octapharma AG Combination Therapy Drug Main Business and Markets Served
Table Kedrion S.p.A Combination Therapy Drug Production Sites and Area Served
Table Kedrion S.p.A Combination Therapy Drug Product Introduction, Application and Specification
Table Kedrion S.p.A Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Kedrion S.p.A Combination Therapy Drug Production Growth Rate (2014-2019)
Table Kedrion S.p.A Combination Therapy Drug Production Market Share (2014-2019)
Figure Kedrion S.p.A Combination Therapy Drug Revenue Market Share (2014-2019)
Table Kedrion S.p.A Combination Therapy Drug Main Business and Markets Served
Table Biotest AG Combination Therapy Drug Production Sites and Area Served
Table Biotest AG Combination Therapy Drug Product Introduction, Application and Specification
Table Biotest AG Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biotest AG Combination Therapy Drug Production Growth Rate (2014-2019)
Table Biotest AG Combination Therapy Drug Production Market Share (2014-2019)
Figure Biotest AG Combination Therapy Drug Revenue Market Share (2014-2019)
Table Biotest AG Combination Therapy Drug Main Business and Markets Served
Table China Biologic Products Combination Therapy Drug Production Sites and Area Served
Table China Biologic Products Combination Therapy Drug Product Introduction, Application and Specification
Table China Biologic Products Combination Therapy Drug Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table China Biologic Products Combination Therapy Drug Production Growth Rate (2014-2019)
Table China Biologic Products Combination Therapy Drug Production Market Share (2014-2019)
Figure China Biologic Products Combination Therapy Drug Revenue Market Share (2014-2019)
Table China Biologic Products Combination Therapy Drug Main Business and Markets Served
Figure Global Combination Therapy Drug Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Combination Therapy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Combination Therapy Drug Sales Price (USD/MT) Forecast 2019-2025
Figure North America Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Combination Therapy Drug Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Combination Therapy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Combination Therapy Drug by Type (2019-2025)
Table Global Consumption (K MT) of Combination Therapy Drug by Application (2019-2025)
Table Combination Therapy Drug Distributors List
Table Combination Therapy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

CSL Ltd、Grifols S.A、Baxalta Incorporated、Octapharma AG、Kedrion S.p.A、Biotest AG、China Biologic Products、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の併用療法薬市場(Global Combination Therapy Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp